# Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

> **NCT00165139** · PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 20 (actual)

## Conditions studied

- Neuroblastoma
- Ewings Sarcoma
- Non-rhabdomyosarcoma Soft Tissue Sarcoma

## Interventions

- **DRUG:** Vincristine
- **DRUG:** Cyclophosphamide
- **DRUG:** Adriamycin
- **DRUG:** Etoposide (VP-16)
- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Melphalan
- **DRUG:** Ifosfamide
- **DRUG:** G-CSF (granulocyte-colony stimulating factor)
- **DRUG:** Mesna

## Key facts

- **NCT ID:** NCT00165139
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-01
- **Primary completion:** 2000-11
- **Final completion:** 2009-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-11-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165139, "Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00165139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*